Publications

This communique summarises the meeting of the Health Technology Assessment (HTA) Review Implementation Advisory Group held on 8 May 2025.

This framework is used by Health Technology Assessment (HTA) Review Implementation Advisory Group members to consider the HTA Review's recommendations.

This communique summarises the meeting of the Health Technology Assessment (HTA) Review Implementation Advisory Group held on 21 March 2025.

This communique summarises the meeting of the Health Technology Assessment (HTA) Review Implementation Advisory Group held on 10 April 2025.

This is the latest report in a series of national quarterly syphilis surveillance reports.

This communique summarises the meeting of the Health Technology Assessment (HTA) Review Implementation Advisory Group held on 11 March 2025

This letter outlines the Minister for Health & Aged Care’s priority areas for IAG consideration.

This communique summarises the meeting of the Health Technology Assessment (HTA) Review Implementation Advisory Group held on 3 February 2025.

Terms of reference for the Health Technology Assessment Review Implementation Advisory Group.

This is the latest report in a series of national quarterly syphilis surveillance reports.

We established an Implementation Advisory Group to develop a roadmap for sequencing the government’s response to the recommendations. This document contains MSAC chair's response to the Minister regarding the final report of the HTA Review and provided their initial advice and reflections.

We established an Implementation Advisory Group to develop a roadmap for sequencing the government’s response to the recommendations. This document contains PBAC chair's response to the Minister regarding the final report of the HTA Review and provided their initial advice and reflections.

This report provides a quarterly account of progress against the targets and indicators in the National strategic approach for responding to rising rates of syphilis in Australia 2021 and National syphilis surveillance and monitoring plan.

This document is the final report from the Health Technology Assessment Policy and Methods Review.

This document summarises the recommendations from the Health Technology Assessment Policy and Methods Review report.

This document outlines all of the recommendations from the Health Technology Assessment Policy and Methods Review final report.

The Enhanced Consumer Engagement Process was developed to provide recommendations on how to increase patient and consumer evidence and input earlier in the Health Technology Assessment (HTA) process. This report explains the recommendations developed by the Co-Design Working Group.

This report provides a quarterly account of progress against the targets and indicators in the National strategic approach for responding to rising rates of syphilis in Australia 2021 and National syphilis surveillance and monitoring plan.

This paper examines emerging health technologies.

This paper examines the Australian market authorisation, funding and assessment pathways and timelines.

This paper examines the pathways, processes and steps used in health technology assessment (HTA) internationally.

This paper provides an overview of the methods used in economic evaluation as part of HTA processes in Australia and other jurisdictions of interest where HTA is used to support reimbursement for new health technologies.

This discussion paper examines local and international approaches for funding and purchasing arrangements and the managing uncertainty.

This paper examines real world evidence to support health technology assessment (HTA) in Australia.

The communique covers the deliberative period of the Health Technology Assessment Policy and Methods Review, leading into the completion of the final report.